Alnylam Pharmaceuticals, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $844.3M | $-708.7M | $-852.8M |
| FY2022 | $1.04B | $-785.1M | $-1.13B |
| FY2023 | $1.83B | $-282.2M | $-440.2M |
| FY2024 | $2.25B | $-176.9M | $-278.2M |
| FY2025 | $3.71B | $501.6M | $313.7M |